Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

Ralf E. Harskamp, Robert M. Clare, Giuseppe Ambrosio, Claes Held, Yuliya Lokhnygina, David J. Moliterno, Harvey D. White, Philip E. Aylward, Paul W. Armstrong, Kenneth W. Mahaffey, Robert A. Harrington, Frans Van de Werf, Lars Wallentin, John Strony, Pierluigi Tricoci

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science